- Nu kommer plasma från den brittiska biobanken UK Biobank till Uppsala. Proverna är kopplade till mycket data om personerna de kommer ifrån, vilket ger möjlighet att tolka information om proteiner i proverna med en teknik utvecklad i Uppsala. https://t.co/iHQAQv9l0x
- Två av de 51 forskningsprojekten i årets 100-lista för innovation kommer från Uppsala universitet. De handlar om utveckling av verktyg för att avslöja hat och extremism på nätet samt en modell för att bättre kunna upptäcka livmoderhalscancer. https://t.co/0jlNORpYfW
- Unmarried or less-educated patients with mantle cell lymphoma are less likely to undergo a transplant, leading to lower survival | Blood Advances | American Society of Hematology https://t.co/yTMp0cVHQy
Welcome to IGP
The department conducts advanced research and education in areas such as clinical immunology, medical genetics and genomics, pathology, oncology, neuro-oncology, vascular biology, molecular tools and medical radiation sciences.
Some of our activities are integrated with clinics at Uppsala University Hospital.
Find examples of research at the department in Our research in images
New research findings from IGP
Immune cells in the tumour associated with worse prognosis for mantle cell lymphoma
Tumour cells can affect immune cells in the body so that the tumour is not attacked by the immune defence. In a new research paper from IGP, the researchers show that some types of immune cells are more common in more aggressive tumours of the cancer form mantle cell lymphoma. The findings suggest a possibility to develop drugs that can improve the prognosis for mantle cell lymphoma patients.
Different therapeutic effects of modified oncolytic viruses
Using oncolytic viruses is a new strategy for cancer immunotherapy. To enhance the therapeutic effect the viruses can be modified with immunostimulatory factors. A study from IGP shows that the effect of such factors depends on the kind of oncolytic virus that is modified. To achieve the desired therapeutic benefits, careful consideration is therefore needed when choosing the virus. The study has been published in the journal Molecular Therapy Oncolytics.
Improved blood vessels in retinopathy with targeted approach
Treatment of the eye disease, retinopathy, aims to reduce the formation of blood vessels in the retina of the eye. To reduce unwanted side effects of such treatments, researchers in Lena Claesson-Welsh’s research group have tested to inhibit the enzyme eNOS and found a reduced formation of dysfunctional vessels in mice with retinopathy while the healthy vasculature in the retina was preserved. The study highlights the importance of targeted approaches in medicine.